News
Sixfold Bioscience to Present Two Talks at NextGen Biomed 2025
LONDON, United Kingdom, 27th February, 2025 — Sixfold Bioscience today announced that Dr Anna Perdrix Rosell, co-CEO/Founder, and Dr Reeta Daswani, Senior Scientist II, will present research on the company’s RNA delivery system as ‘Key Speakers’ at the upcoming conference ‘NextGen Biomed 2025’. Dr Rosell will further facilitate the meeting as Chair for the conference track: ‘Oligonucleotide Discovery & Sustainable Approaches’.
The three day conference held in London on the 12-14th of march 2025 will cover a range of topics on sequence driven therapeutics, and will feature leading industry experts from the fields of RNA, Peptides and Antibodies, including: Roche, AstraZeneca, GSK, Genentech, Moderna and Sanofi.
Dr Anna Perdrix Rosell
Track Keynote: March 14th, 09:00am (GMT)
Dr Reeta Daswani
Presentation: March 12th, 12:05pm (GMT)
Sixfold Bioscience is solving one of the most critical challenges preventing the greater utilisation of RNA: delivery. Using advanced AI/ML, automated chemistry and high throughput screening, Sixfold is learning the language that encodes RNA destination and unlocking new cell types for treatment.
